Submit a Project Concept

Researchers interested in submitting a Project Concept to The Biomarkers Consortium should complete this Project Concept Submission Form and send it via e-mail to the Foundation for the National Institutes of Health at biomarkers@fnih.org.

The purpose of the submission is to succinctly and clearly define the background and rationale for the proposed project, and to describe findings that demonstrate the feasibility of the proposed study and the likelihood of the expected outcome. Approval of project concepts are based on (1) suitability to the goals of The Biomarkers Consortium, (2) scientific importance, (3) clinical importance, (4) regulatory importance, (5) feasibility, (6) degree of providing commercial implications, and (7) whether partners have been identified to conduct and fund the project.

Project Concepts for any therapeutic area of biomedical research are encouraged.  Upon submission of a project concept, the project concept will be sent to the appropriate Steering Committee for review.  If there is no Steering Committee for the proposed therapeutic area of research, the project concept will be sent directly to the Executive Committee for review.  

Should a project concept be approved by the relevant Steering Committee (or the Executive Committee) for further development, a Project Team will be assembled that includes the submitter(s) and other interested parties representing government, academia, and the private and non-profit sectors.  The Project Team, with support from the assigned Consortium Scientific Program Manager, will develop a full Project Plan (using the Consortium's Project Plan Template describing the proposed details of the project.

Note that The Biomarkers Consortium is not a funding entity. The consortium is soliciting promising biomarker concepts which, if approved for implementation, may be developed further. Upon approval, the Foundation for the National Institutes of Health will seek the donations needed to carry out the project.

For more information about Project Concept submissions to The Biomarkers Consortium, please contact us at biomarkers@fnih.org.

 

  • About Biomarkers

    Biomarkers are characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention. More

  • Join Us

    Become a Member
    Learn how you can join and support The Biomarkers Consortium.

    The Biomarkers Consortium embraces government, industry, patient advocacy groups, and non-profit organizations, each of which has a stake in the development of biomarker technology.

  • Latest News

    THE BIOMARKERS CONSORTIUM LAUNCHES I-SPY 2 BREAST CANCER CLINICAL TRIAL:  Click here to read the press release.

    March 17, 2010 -- Announcing the launch of the Biomarkers Consortium I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging and moLecular analysis): An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy), which is taking place today from 9-10:30 a.m. ET at the National Press Club, Washington, DC.  Click here for more information.

    View the Web Cast

     

    Six awardees conducting data analysis to Develop Clinical Criteria for the Diagnosis of Clinically Important Weakness Associated with Low Muscle Mass in Older Adults: Click here to read

    The Metabolic Disorders Steering Committee releases strategy for Mathematical Modeling in Atherosclerosis:  Details

    PRESS RELEASE:  The Biomarkers Consortium Completes First Project to Show That Adiponectin is a Predictive Biomarker for Type 2 Diabetes:  Click here to read

    RFP for Data Analysis to Develop Clinical Criteria for the Diagnosis of Clinically Important Weakness Associated with Low Muscle Mass in Older Adults.  Due Date: September 8, 2009.  Click here to read.

     

    Available Now: The Biomarkers Consortium Report, Volume 1, Issue 1, May 2009. Click Here to Read

    The Metabolic Disorders Steering Committee Prioritized Areas of Unmet Need: As advertised in Volume 58, No. 4, April 2009 issue of Diabetes.  Click Here to read.

    Presentations Available from the Beta Cell Function Symposium. Click here for agenda.